Fundraising FoxBrandaris Therapeutics
Leiden, NL · 1 known investors
Find your way into Brandaris Therapeutics
Sign up to see every warm intro you have to Brandaris Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brandaris Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Brandaris Therapeutics is a translational-stage biotech developing first-in-class and best-in-class small-molecule therapies for neuropsychiatric disorders such as depression and anxiety, using a differentiated approach to receptor pharmacology. Its drug candidates aim to provide rapid-onset, durable efficacy with improved side-effect profiles for patients with mental health disorders.
Investors · 1
Frequently asked questions
- What does Brandaris Therapeutics do?
- Brandaris Therapeutics is a translational-stage biotech developing first-in-class and best-in-class small-molecule therapies for neuropsychiatric disorders such as depression and anxiety, using a differentiated approach to receptor pharmacology. Its drug candidates aim to provide rapid-onset, durable efficacy with improved side-effect profiles for patients with mental health disorders.
- Who are Brandaris Therapeutics's investors?
- Brandaris Therapeutics's investors include BioGeneration Ventures.
- Where is Brandaris Therapeutics headquartered?
- Brandaris Therapeutics is headquartered in Leiden, NL.